Literature DB >> 31423948

Characterization of the stemness potency of mammospheres isolated from the breast cancer cell lines.

Saghar Yousefnia1, Kamran Ghaedi1,2, Farzad Seyed Forootan2,3, Mohammad Hossein Nasr Esfahani2.   

Abstract

Stemness phenotype mammospheres established from cell lines and tissues taken from autopsy can be used to test and to identify the most sensitive drugs for chemotherapy. Therefore, the aim of the present study was isolation and characterization of cancer stem cells derived from MCF7, MDA-MB231, and SKBR3 breast cancer cell lines to demonstrate the stemness phenotypes of mammospheres generated for further their applications in therapeutic approaches. In this study, two luminal subtypes of cell lines, MCF7 and SKBR3 and a basal subtype cell line, MDA-MB-231, were chosen. Mammosphere culturing was implemented for breast cancer stem cells isolation and mammosphere formation efficiency. At the next step, CD44+/CD24- cell ratio, Oct4 and Nanog mRNA levels, proliferation rate, migration rate of mammospheres, and drug resistance (in third passage) were evaluated. In addition, tumorigenicity of mammospheres in the chick embryo model was evaluated and compared through the chick chorioallantoic membrane assay. Among mammospheres formed in all three cell lines, MCF7 had the highest mammosphere formation efficiency. CD24 marker (a differentiation marker for the breast cancer cells) was significantly reduced in the mammospheres generated from MCF7 and SKBR3, during three passages. Also, Oct4 and Nanog transcript levels were significantly higher in all three types of mammospheres, as compared with their cell lines. Proliferation, migration rate, and drug resistance of mammospheres generated from all three cell lines were found to be significantly higher. Tumorigenicity of MCF7 mammospheres was confirmed through tumor size measurement. Also, tumorigenicity of MCF7 and SKBR3 mammospheres was confirmed through more migration from ectoderm to mesoderm and endoderm. We succeeded to establish the technology that can be extended to tissue in the future. We have demonstrated a number of mammospheres can be generated from cell lines. Also, cells with different molecular features showed different stemness phenotypes.

Entities:  

Keywords:  Breast cancer stem cell; CD44+/CD24–; MCF7; MDA-MB-231; SKBR3; mammosphere

Mesh:

Substances:

Year:  2019        PMID: 31423948     DOI: 10.1177/1010428319869101

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

1.  DPYSL2 interacts with JAK1 to mediate breast cancer cell migration.

Authors:  Areej Abu Rmaileh; Balakrishnan Solaimuthu; Anees Khatib; Shirel Lavi; Mayur Tanna; Arata Hayashi; Michal Ben Yosef; Michal Lichtenstein; Nir Pillar; Yoav D Shaul
Journal:  J Cell Biol       Date:  2022-05-16       Impact factor: 8.077

Review 2.  The 3D in vivo chorioallantoic membrane model and its role in breast cancer research.

Authors:  Cynthia Kohl; Thiha Aung; Silke Haerteis; Atanas Ignatov; Olaf Ortmann; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-05       Impact factor: 4.322

3.  Mortalin maintains breast cancer stem cells stemness via activation of Wnt/GSK3β/β-catenin signaling pathway.

Authors:  Bo Wei; Jia Cao; Jin-Hai Tian; Chuan-Yang Yu; Qi Huang; Jing-Jing Yu; Rong Ma; Jia Wang; Fang Xu; Li-Bin Wang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

4.  Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.

Authors:  Sandra Marijan; Anita Markotić; Angela Mastelić; Nikolina Režić-Mužinić; Lisa Ivy Pilkington; Johannes Reynisson; Vedrana Čikeš Čulić
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

5.  Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.

Authors:  Inés Velázquez-Quesada; Angel J Ruiz-Moreno; Diana Casique-Aguirre; Charmina Aguirre-Alvarado; Fabiola Cortés-Mendoza; Marisol de la Fuente-Granada; Carlos García-Pérez; Sonia M Pérez-Tapia; Aliesha González-Arenas; Aldo Segura-Cabrera; Marco A Velasco-Velázquez
Journal:  Drug Des Devel Ther       Date:  2020-05-12       Impact factor: 4.162

Review 6.  Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.

Authors:  Saghar Yousefnia; Farzad Seyed Forootan; Shiva Seyed Forootan; Mohammad Hossein Nasr Esfahani; Ali Osmay Gure; Kamran Ghaedi
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

7.  Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.

Authors:  Claudia Urueña; Tito A Sandoval; Paola Lasso; Mauricio Tawil; Alfonso Barreto; Lilian Torregrosa; Susana Fiorentino
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

8.  The Chick Chorioallantoic Membrane Model: A New In Vivo Tool to Evaluate Breast Cancer Stem Cell Activity.

Authors:  Marta Teixeira Pinto; Ana Sofia Ribeiro; Inês Conde; Rita Carvalho; Joana Paredes
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

9.  Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics.

Authors:  Jessica Dörnen; Ola Myklebost; Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

10.  Mapping a Circular RNA-microRNA-mRNA-Signaling Regulatory Axis That Modulates Stemness Properties of Cancer Stem Cell Populations in Colorectal Cancer Spheroid Cells.

Authors:  Vimalan Rengganaten; Chiu-Jung Huang; Ping-Hsing Tsai; Mong-Lien Wang; Yi-Ping Yang; Yuan-Tzu Lan; Wen-Liang Fang; Shelly Soo; Hooi Tin Ong; Soon Keng Cheong; Kong Bung Choo; Shih-Hwa Chiou
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.